Embodiments of the invention relate to methods of reducing weight in mammals and for the prophylaxis or treatment of obesity comprising administration of C2-substituted indan-1-one systems and their physiologically acceptable salts and physiologically functional derivatives. Compounds for use in methods of embodiments of the invention may include compounds of the formula ##STR1##

in which the radicals are as defined, and their physiologically acceptable salts.

 
Web www.patentalert.com

< Regulation of intracellular glucocorticoid concentrations

< Compounds for the treatment of metabolic disorders

> Arylpiperazines having activity at the serotonin 1A receptor

> Smooth muscle controller

~ 00208